101 related articles for article (PubMed ID: 19363272)
1. Near-infrared spectroscopy of blood plasma for diagnosis of sporadic Alzheimer's disease.
Burns DH; Rosendahl S; Bandilla D; Maes OC; Chertkow HM; Schipper HM
J Alzheimers Dis; 2009; 17(2):391-7. PubMed ID: 19363272
[TBL] [Abstract][Full Text] [Related]
2. Discrimination analysis of blood plasma associated with Alzheimer's disease using vibrational spectroscopy.
Carmona P; Molina M; Calero M; Bermejo-Pareja F; Martínez-Martín P; Toledano A
J Alzheimers Dis; 2013; 34(4):911-20. PubMed ID: 23302656
[TBL] [Abstract][Full Text] [Related]
3. Infrared spectroscopy: a reagent-free method to distinguish Alzheimer's disease patients from normal-aging subjects.
Peuchant E; Richard-Harston S; Bourdel-Marchasson I; Dartigues JF; Letenneur L; Barberger-Gateau P; Arnaud-Dabernat S; Daniel JY
Transl Res; 2008 Sep; 152(3):103-12. PubMed ID: 18774539
[TBL] [Abstract][Full Text] [Related]
4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
5. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
6. Methodology for discovery of Alzheimer's disease blood-based biomarkers.
Maes OC; Schipper HM; Chertkow HM; Wang E
J Gerontol A Biol Sci Med Sci; 2009 Jun; 64(6):636-45. PubMed ID: 19366883
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
[TBL] [Abstract][Full Text] [Related]
8. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
[TBL] [Abstract][Full Text] [Related]
10. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
[TBL] [Abstract][Full Text] [Related]
11. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
[TBL] [Abstract][Full Text] [Related]
12. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
13. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
14. Heteroplasmy of mitochondrial D310 mononucleotide repeat region in the blood of patients with Alzheimer's disease.
Wang PN; Lee HC; Wang CH; Ping YH; Liu TY; Chi CW; Lin KN; Liu HC
J Alzheimers Dis; 2009; 18(2):345-53. PubMed ID: 19584455
[TBL] [Abstract][Full Text] [Related]
15. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
16. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
[TBL] [Abstract][Full Text] [Related]
17. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
[TBL] [Abstract][Full Text] [Related]
18. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.
Song F; Poljak A; Smythe GA; Sachdev P
Brain Res Rev; 2009 Oct; 61(2):69-80. PubMed ID: 19464319
[TBL] [Abstract][Full Text] [Related]
19. A gene expression pattern in blood for the early detection of Alzheimer's disease.
Booij BB; Lindahl T; Wetterberg P; Skaane NV; Sæbø S; Feten G; Rye PD; Kristiansen LI; Hagen N; Jensen M; Bårdsen K; Winblad B; Sharma P; Lönneborg A
J Alzheimers Dis; 2011; 23(1):109-19. PubMed ID: 20930264
[TBL] [Abstract][Full Text] [Related]
20. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
